Inhibition of Raf-1 protein kinase by antisense phosphorothioate oligodeoxyribonucleotide is associated with sensitization of human laryngeal squamous carcinoma cells to gamma radiation

Cancer Journal from Scientific American

Volumn 3, Issue 1, 1997, Pages 13-20

  Soldatenkov, Viatcheslav A ^a   Dritschilo, Anatoly ^a   Wang, Fuh Han ^a   Olah, Zoltan ^b   Anderson, Wayne B ^b   Kasid, Usha ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

antisenae oligodeoxyribonucleotide; head and neck squamous cell carcinoma; radiosensitizer; Raf 1

Indexed keywords

OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PROTEIN KINASE; RAF PROTEIN;

ARTICLE; CELL CULTURE; CELL VIABILITY; CLONOGENIC ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; GAMMA RADIATION; HUMAN; HUMAN CELL; LARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; SENSITIZATION; SQUAMOUS CELL CARCINOMA;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL SURVIVAL; GAMMA RAYS; HUMANS; LARYNGEAL NEOPLASMS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RAF; RADIATION-SENSITIZING AGENTS; SUBSTRATE SPECIFICITY; THIONUCLEOTIDES; TUMOR CELLS, CULTURED;

EID: 0030894324     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Weichselbaum RR, Dahlberg W, Beckett M et al. Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients. Proc Natl Acad Sci USA 1986;83:2684-2688.
2. Kasid U, Pirollo K, Dritschilo A et al. Oncogenic basis of radiation resistance. Adv Cancer Res 1993;61:195-233.
3. Kasid U, Pfeifer A, Brennan T et al. Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma. Science 1989;243:1354-1356.
4. Agrawal S, Goodchild J, Civera MP et al. Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus. Proc Natl Acad Sci USA 1988;85: 7079-7083.
5. Monia BP, Johnston JF, Ecker DJ et al. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J Biol Chem 1992;267:19954-19962.
6. Stein CA, Cheng Y-C. Antisense oligonucleotides as therapeutic agents: is the bullet really magical? Science 1993;261:1004-1012.
7. Wagner RW. Gene inhibition using antisense oligodeoxynucleotides. Nature 1994;372:333-335.
8. Telford WG, King LE, Fraker PJ. Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry 1992;13: 137-143.
9. Brown TA, ed. Molecular Biology LabFax. Oxford: BIOS Scientific Publishers Ltd.; 1991:88.
10. Albright N. Computer programs for the analysis of cellular survival data. Radiat Res 1987;112:331-340.
11. Bonner TJ, Oppermann H, Seeberg P et al. The complete coding sequence of the human raf oncogene and the corresponding structure of the c-raf-1 gene. Nucleic Acid Res 1986;14: 1009-1015.
12. Sinclair WK. Cyclic x-ray responses in mammalian cells in vitro. Radiat Res 1968;33:620-643.
13. 1 and S in CD3-stimulated primary human Tcells. Molec Cell Biol 1991;11:2794-2803.
14. Fertil B, Malaise EP. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 1985;11:1699-1707.
15. Dritschilo A Cancer and Carcinogenesis. In: Mossman KL, Mills WA, eds. The Biological Basis of Radiation Protection Practice. Philadelphia: Williams and Wilkins; 1992:77-88.
16. Hall EJ. Radiobiology for the Radiologist. 3rd ed. Philadelphia: J.B. Lippincott Co.; 1988.
17. Kasid U, Suy S, Dent P et al. Activation of raf by ionizing radiation. Nature 1996;382:813-816.
18. Rapp UR. Role of Raf-1 serine/threonine protein kinase in growth factor signal transduction. Oncogene 1991;6:495-500.
19. Weichselbaum RR, Hallahan DE, Sukhatme V et al. Biological consequences of gene regulation after ionizing radiation exposure. J Natl Cancer Inst 1991;83:480-484.
20. Riva C, Lavieille J-P, Reyt E et al. Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck implication in drug and radioresistance. Oral Oncol Eur J Cancer 1995;31B:384-391.
21. Patel BKR, Kasid U. Nucleotide sequence analysis of c-raf-1 cDNA and promoter from a radiation-resistant human squamous carcinoma cell line: deletion within exon 17. Molecul Carcinogen 1993;8:7-12.
22. Wagner RW. Commentary: the state of the art in antisense research. Nature Medicine 1995;11:1116-1118.
23. Stein CA. Commentary: does antisense exist? Nature Medicine 1995;11:1119-1121.
24. Stein CA, Krieg A, Problems in interpretation of data derived from in vitro and in vivo use of antisense oligonucleotides. Antisense Res Devel 1994;4:67-69.
25. Wickstrom EL, Bacon TA, Gonzales A et al. Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc Natl Acad Sci USA 1988;85: 1028-1032.
26. Thierry AR, Dritschilo AD. Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynudeotides for antisense activity. Nucleic Acids Res 1992;20: 5691-5698.
27. Thierry AR, Rahman A, Dritschilo A. Liposomal delivery as a new approach to transport antisense oligonucleotides. In: Erickson RP, Izant JG, eds. Gene Regulation: Biology of Antisense RNA and DNA New York Raven Press, Ltd.; 1992:147-161.
28. Tamamoto T, Yamamoto S, Kataoka T et al. Ability of oligonucleotides with certain palindromes to induce interferon production and augment natural killer cell activity is associated with their base length. Antisense Res Devel 1994;4:119-122.
29. Krieg A, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995;374:546-549.